throbber
1§NEPHROL 2011; 24(01): 106-111
`WWWWWWWWWWWWWWWWWWW
`
`
`
`‘ m sits-1
`
`«mt-t -
`
`Fig. 3 - Treatment with rhlL-11 in nephrotoxic nephritis (NTN).
`Treatment with high-dose lL-11 reduced expression of glom-
`erular TGF-B1 (A), glomerular tx-SMA (C), periglomerular
`tx-SMA (D), glomerular fibronectin (E) and periglomerular
`fibronectin (F) in comparison with vehicle-treated rats. The
`reduction in glomerular p-p38 MAPK (B) was not significant.
`
`
`
`In this study, we have shown that treatment with a high
`dose of lL-11 reduced glomerular expression of TGIF-(31,
`Oi-SMA and fibronectin in NTN. To our knowledge, the
`present study is the first demonstration that administration
`of rhlL-11 may alleviate glomerular expression of TGIF-B1
`activation of myofibroblasts and extracellular matrix depo-
`sition in experimental glomerulonephritis.
`In the kidney, myofibroblasts may derive from perivasoular
`smooth muscle cells, pericytes and interstitial fibroblasts,
`after stimulation by cytokines such as TGF-B1 and lL-1B
`(15-17). Myofibroblasts are implicated in the development
`
`of sclerotic lesions (18, 19). Adenoviral gene transfer of
`soluble TGF-B1 receptor || reduced the number of OI-SMA
`(+) cells and ameliorated interstitial fibrosis in NTN (20). In
`our study, a-SMA was expressed initially in the periglom-
`erular area on day 4; however, its periglomerular as well as
`mesangial expression was increased on clay 6, when the fi-
`bronectin expression was also increased. The periglomeru-
`lar a-SMA up-regulation can be attributed to myofibroblast
`formation. Activated myofibroblasts become hypertrophic
`and secrete extracellular matrix proteins, and this may lead
`to glomerulosclerosis, fibrous crescent formation and tubu-
`lointerstitial fibrosis (18).
`Phosphorylation and activation of p38 MAPK was noticed
`very early, only 5 hours after NTS induction, but most inter-
`estingly, its activation happened in a repeated way. P-p38
`MAPK expression was increased 5 hours after induction
`of NTN, reduced to normal levels during days 2-4 and re-
`lapsed on day 6. Transient inactivation of p-p38 MAPK may
`be due to its interaction with MAPK phosphatases (MKPs).
`MKPs are a family of protein phosphatases, which are re-
`sponsible for the dephosphorylation and inactivation of
`MAPKs. MKPs are activated simultaneously with MAPKs
`(20, 21), and they may be responsible for p-p38 MAPK in-
`activation.
`In the present study this inactivation seemed
`to be transient, because p38 MAPK was reactivated later,
`probably as a result of cytokine and growth factor produc-
`tion. To our knowledge, this dual activation of p38 MAPK
`has not been described previously; however, more specific
`studies are necessary to investigate it further.
`There was only a small reduction in renal p-p38 MAPK ex-
`pression in lL-11—treated rats. These results suggest that
`glomerular expression of TGF-[31 and infiltration/transfor-
`mation of myofibroblasts may proceed independently of
`p-p38 MAPK, this is in accordance with a previous study,
`which showed that p-p38 MAPK was not the only down-
`stream signalling intermediate in the pathway from TGIF-B1
`to a-SMA (22). Also, administration of a TGF-B1 receptor
`inhibitor (SD-208) resulted in the attenuation myofibroblast
`transformation of lung fibroblasts, an effect that could not
`be achieved by a p38 MAPK inhibitor(SD 282) (2 ).
`In our previous report, both high and low doses of lL-11
`reduced proteinuria and glomerular fibrinoid necrosis, but
`had a different effect on glomerular macrophages (10). Dai-
`ly treatment with a high close (1,360 ug) of rhlL—11 reduced
`the number of infiltrating macrophages; a low dose (800
`ug) of rhlL-11 reduced only the number of activated mac-
`rophages, not the total number of macrophages. Based on
`this reduction, the anti-TGF effect of lL-11 could be attrib-
`uted to its anti-inflammatory properties, a mechanism that
`has also been described for other agents (24). However,
`
`© 2011 Societa Italiana di Nefl'ologia , ISSN 112178428
`
`1 09
`
`Ex. 2001 - Page1544
`Ex. 2001 - Page1544
`
`

`

`WWWWWWWWWWWWWWWWWWW
`Stangou et al: Anti-TGF effect of lL-11 in glomerulonephritis
`
`the fact that low-dose rhlL-11 was enough to reduce IL-
`10 production, and macrophage activity, but not TGF-B1,
`ot-SMA and fibronectin expression, makes the position
`more complicated. It seems that administration of rhlL—11
`has the potential to reduce inflammation, even when giv-
`en at lower doses, but this anti-inflammatory effect is not
`enough to justify its anti-TGF effect, which requires higher
`dosage, and is also independent from p38 MAPK dephos-
`phorylation and inactivation. One of the speculations is that
`the reduction in the number of glomerular macrophages is
`needed to reduce the TGIF-[31 expression. Further work is
`needed to investigate this possibility.
`Findings of the present study suggest that lL-11 has a
`dose-dependent effect in glomerular expression of TGF-B1,
`myofibroblast differentiation and extracellular matrix depo-
`sition in NTN. This finding may be of relevance to develop-
`ment of possible new applications of lL-11 and also novel
`treatment strategies in patients with glomerulonephritis.
`
`Financial support: This work was supported by a research project
`grant from Kidney Research UK. MS. received a research project
`grant from the Greek Renal Association.
`
`Conflict of interest statement: James C. Keith Jr is an employee of
`Wyeth Research, Cambridge, MA, USA.
`
`Address for correspondence:
`Maria Stangou, MD
`Nephrology Department Aristotle University
`Hippokration Hospital
`50 Papanastasiou Street
`Thessaloniki, Greece
`mstangou@math.com
`
`2.
`
`3.
`
`4.
`
`
`1.
`Trepicchio WL, Dorner AJ. Interleukin-11: a gp130 cytokine.
`Ann N YAcad Sci. 1998;856:12-21.
`MUIIer—Newen G. The cytokine receptor gp130: faithfully pro-
`miscuous. Sci STKE. 2003;2003:PE40.
`Heinrich PC, Behrmann l, Haan S, Hermanns HM, Muller—
`Newen G, Schaper F. Principles of
`interleukin (lL)-6—
`type cytokine signalling and its regulation. Biochem J.
`2003;374:1-20.
`Schwertschlag US, Trepicchio WL, Dykstra KH, Keith JC,
`Turner KJ, Dorner AJ. Hematopoietic,
`immunomodula—
`tory and epithelial effects of
`interleukin-11. Leukemia.
`1999;113:1307-1315.
`Kurzrock R, Cortes J, Thomas DA, Jeha S, Pilat S, Talpaz M.
`Pilot study of low—dose interleukin—11 in patients with bone
`marrow failure. J Clin Oncol. 2001 :19:4165—4172.
`Ragni MV, Jankowitz RC, Chapman HL, et al. A phase II
`prospective open-label escalating dose trial of recombinant
`interleukin-11 in mild von Willebrand disease. Haemophilia.
`2008;14:968—977.
`Schmitz B, Thiele J, Witte O, Kaufmann R, Wickenhauser C,
`Fischer R. Influence of cytokines (IL-1 alpha, lL-3, lL-11, GM-
`CSF) on megakaryocyte-fibroblast interactions in normal hu-
`
`5.
`
`6.
`
`7.
`
`8.
`
`man bone marrow. Eur J Haematol. 1995;55:24—32.
`Peterson RL, Wang L, Albert L, Keith JO Jr, Dorner AJ. Mo-
`lecular effects of recombinant human interleukin-11 in the
`
`9.
`
`10.
`
`11.
`
`HLA-B27 rat model of inflammatory bowel disease. Lab In-
`vest. 1998;78:1503—1512.
`Tang W, Geba GP, Zheng T, et al. Targeted expression of IL—
`11 in the murine airway causes lymphocytic inflammation,
`bronchial remodeling, and airways obstruction. J Clin Invest.
`1996;923:2845-2853.
`Lai PC, Cook HT, Smith J, Keith JC Jr, Pusey CD, Tam FW.
`Interleukin—11 attenuates nephrotoxic nephritis in Wistar
`Kyoto rats. J Am Soc Nephrol. 2001;12:2310-2320.
`Lai PC, Smith J, Bhangal G, et al.
`lnterteukin-11 reduces
`renal
`injury and glomerular NF-kappa B activity in murine
`experimental glomerulonephritis. Nephron Exp Nephrol.
`2005;101:146—154.
`12. Tam FW, Smith J, Morel D, et al. Development of scarring
`and renal failure in a rat model of crescentic glomerulone-
`phritis. Nephrol Dial Transplant. 1999;14:1658-1666.
`13. Martin MM, Buckenberger JA, Jiang J, et al. TGF—beta1 stim—
`ulates human AT1 receptor expression in lung fibroblasts by
`cross talk between the Smad, p38 MAPK, JNK, and PI3K
`signaling pathways. Am J Physiol Lung Cell Mol Physiol.
`2007;293:790-799.
`14. Kutz SM, Hordines J, McKeown—Longo PJ, Higgins PJ. TGF—
`
`110
`
`© 2011 Societa Italiana di Nefrologia - ISSN 11218428
`
`Ex. 2001 - Page1545
`Ex. 2001 - Page1545
`
`

`

`§EPHROL 2011; 24(01): 106-111
`WWWWWWWWWWWWWWWWWWW
`
`15.
`
`16.
`
`17.
`
`18.
`
`19.
`
`20.
`
`B1—induced PAl—1 gene expression requires MEK activity and
`cell-to-substrate adhesion. J Cell Sci. 2001 ;1 14:3905-3914.
`Vesey DA, Cheung CW, Cuttle L, Endre ZA, Gobe G, Johnson
`DW. Interleukin-1 beta induces human proximal tubule cell in-
`jury, alpha—smooth muscle actin expression and fibronectin
`production. Kidney Int. 2002;62:31—40.
`Kondo S, Kagami S, Urushihara M, et al. Transforming growth
`factor-beta1 stimulates collagen matrix remodeling through
`increased adhesive and contractive potential by human renal
`fibroblasts. Biochim Biophys Acta. 2004;1693:91—100.
`Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri Fl.
`Fibroblasts in kidney fibrosis emerge via endothelial-to-mesen-
`chymal transition. J Am Soc Nephrol. 2008;193:2282-2287.
`Goumenos D, Tsomi K, latrou C, et al. Myofibroblasts and
`the progression of crescentic glomerulonephritis. Nephrol
`Dial Transplant. 1998;13:1652—1661 .
`Roberts IS, Burrows C, Shanks JH, Venning M, McWilliam
`LJ. Interstitial myofibroblasts: predictors of progression in
`membranous nephropathy. J Clin Pathol. 1997;50:123-127.
`Zhou A, Ueno H, Shimomura M, et al. Blockade of TGF—beta
`action ameliorates renal dysfunction and histologic progres—
`sion in anti-GBM nephritis. Kidney Int. 2003;64:92-101.
`
`21.
`
`22.
`
`23.
`
`24.
`
`Dickinson RJ, Keyse SM. Diverse physiological functions
`for dual-specificity MAP kinase phosphatases. J Cell Sci.
`2006;119:4607-4615.
`Ding Q, Gladson CL, Wu H, Hayasaka H, Olman MA. Fo-
`cal adhesion kinase (FAK)—related non—kinase inhibits
`myofibroblast differentiation through differential MAPK
`activation in a FAK-dependent manner. J Biol Chem.
`2008;283:26839-26849.
`Kapoun AM, Gaspar NJ, Wang Y, et al. Transforming growth
`factor—beta receptor type 1
`(TGFbetaRl) kinase activity but
`not p38 activation is required for TGFbetaRl—induced myofi—
`broblast differentiation and profibrotic gene expression. Mol
`Pharmacol. 2006;70:518-531.
`Nagatoya K, Moriyama T, Kawada N, et al. Y—27632 prevents
`tubulointerstitial fibrosis in mouse kidneys with unilateral ure—
`teral obstruction. Kidney Int. 2002;651:1684—1695.
`
`Received: July 14, 2009
`Revised: February 22, 20 7 0
`Accepted: March 0 7, 20 70
`
`© 2011 Societa Italiana di Nefrologia , ISSN 112178428
`
`111
`
`Ex. 2001 - Page1546
`Ex. 2001 - Page1546
`
`

`

`THE JOURNAL OF BI
`I<3 19:78 by The Arm.
`
` K.
`
`
`Jeralshfv and Molecular Biology, 1444:
`
`Transforming Growth Factorwfl Stimulates luterleukln-ll
`Transcription Via Complex Activating Proteinmlailepemieut
`Pathways*
`
`(lfiaceived for puhli alien, September 3-3, 1997, and in revised form, December 19., 1997)
`
`
`Weiliang Tangi, Llu Yang§, Yul-Chung Ya44g§, Shawn X. Lengé, and Jack A. Eliasi‘l‘:
`
`
`
`Fir-m, r'he '
`echo/.3 of Pulmonary and. (Jihad Care 133’.
`'rLe, Yale Unil'e
`fy 843has]. of Mledicirze, Department of Inferno?
`
`t 065.91'}-8057 and §Indiana Um}
`
`.Lry School 0,4 Li 4dicing, Departn‘zcnts offifedicme
`Mcduine, New Haven Lonnec
`(Homotologv/Oncmogv), and BiochemistrylM’chcular Bioiogy, Walth
`(3r Oncology, cmLcr, Indianapoiis. Indiana 4‘220.?
`
`Studies were undertaken to characterize the mecha-
`nism by which transforming growth factor-.61 (TGF—fi.)
`stimulates epithelial cell interleukin (Ha-ll production.
`Nuclear run—0n studies demonstrated that TGF—fi] is a
`potent stimulator (3f lL-ll gene transcription. THE-431
`also stimulated the luciferase activity in cells trans
`fected with reporter gem: constructs containing nude»
`otides ~728 to +58 of the ILull. promoter. Studies with.
`progressive 5" deletion constructs and site-specific mun
`tatlons demonstrated that this stimulation was depend.»
`cut on 2 AP-l sites between nucleoticies -— 10:53 and "-82 in
`the 1142—11 promoter. Mobility shift assays demonstrated
`that TGFvfil stimulated AP-l protein-DNA bincfing to
`both AP- 1 sites. Super-shift analysis demonstrated that
`Junfl was the. major moiety contributing to AP-1 -DNA
`binding in unstimulated! cells and that c-J4141-. Fra——l-,
`and Fra-Z-DNA binding were increased whereas Jun!)-
`DNA binding was (leer-eased in TGF—fil-stimulatecl cells.
`The. sequence in the ID“ promoter that contains the
`AP-l. sites also conferred. TGF-fil responsiveness, in a
`Izosltionnlntlependent 'fl’ashlon, on a lieterologeus minim
`mal promoter. Thus, TGF-Bl stimulates IL-ll gene tram»
`fieripfion Via. a complex AP-l dependent pathway that is
`(lcpemlent on 2 AP-l motifs between. nucleotides —1|.1}(1
`and "-82 that function as an enhancer in the lL-ll
`promoter.
`
`Interle ohm—11 (IL-11)1 was originally discovered as a soluble
`factor 4'14 supernatants from transformed Shame}. cells that
`Stimulated plasmacytoma cell proliferation (1‘4. It. has subse-
`q uently been shown to be a pleiotropic member ol’the I] 6-type
`cylcklue family that mediates
`
`s biologic 2 Villas V43.ahmdlug‘
`
`
`to a multimeric receptor complex 41', at contains the 543130 mol-
`eculc’2-u5) Among its many effects 444£3 the ahihy 1:0 regulate.
`hematopo-esls. rsLilo-dale the prod:Action (at aculc phase pro-
`
`t-z3444s induce 1:he tib
`, )i?:04 of metalloprotclnasc4, 4£'3gu-
`
`
`* This wmk was supported by National l44n1.i1441es of Heallh Giants
`
`I’ll—44313708. ABS/4953, l’ll4-549897 lllrfifiSé‘
`’to.:'. A. E.). DK~50570 and
`3.37.). The costs of publication 01 tHi: "Micle were
`Ill-48819 (to V.
`
`
`deFrayefl in part by the paynmnt of page Charges. Tl
`"tmle 4444154.
`
`therefore be hereby marked “advertis 71.42215" in accordance with 18
`
`USC Section 1734 solely to indicat-e t
`3 fact.
`.ion 01' Pulmo-
`.431: Sr:
`ll 0 Whom correspondence should be addr
`
`
`
`
`
`harmand Crii. cal Co>4re Medicine. Yale loiver. lty School 01’ Vladiu'ue.
`Dept. oflutcmal Medicine, 333 ledar $131105 14'. New Haven, CT
`
`
`0652
`Tel; 203-
`.-4lo‘i.: Fax: 203-3 533826;
`E—mull:
`jack.
`
`eliasfié‘ya" '3. ed 44.
`‘F—f}.. translbrming
`1 The abbrc
`tions need 3449: 1L. i4 e4leuhin;
`
`
`
`
`growll“ 133.0th[34; Al” 1, athV’dhll’l’ pr-th11; l’LV, respl (wary syncytial
`
`
`
`
`vf
`'44s; DMEM Dul‘oecl‘os modified Eagles medium; Dl‘l‘, ditl '4thre-
`
`itol; EMSA, e .clrophm. 4lC mobility shift 34.5533.3; hp, ha, 53 pal,
`.k.
`14hymidiue 1414424563.
`
`late bone metabolism, and alter epithelial proliferah(4n =2,
`6—10). Studies from our laboratories and others have also (lem—
`onstrated that IL-11 can induce tissue fibrosis, regulate tissue
`(nym‘yte and myofibrohlast accumulation, alter airway physi—
`ology, and confer protection in the context ofmncosal injury of
`the resplrator 7 and gastrointestinal tracts (11—143.
`In keeping with the biologic. importance ofIL-ll. a number or
`444"%tlgators have studied its sites of croductlon and the reg»
`4.41at4o4‘4 ol these responses. These stodles demonstrated that
`
`IL-ll is produced by a varlety of stromal cells '
`response to a.
`variety of stimuli. including (:57tokines,histaminc, cosinophil
`\.
`
`
`major basic protein. and r p'iratory tropu: Viruses ('7, 15—20). A.
`prominent finding in our inches of fibroblasts; {18), epithelial
`cells (19), and 04444044444444: (20) and studio? by others of Chon-
`(lrocyles and :;rrioviocyles (’7‘ has been the imporLance of
`TGF- 43 moieties 4n the 3414mulat4tm ol' ll. 1] product4o44 Whose
`studies also demonstrated that TG‘rF—p1 stimulamon of IL—11
`
`protein production is as slated with proportionate changes in
`lL~ll mRNA accumulation and7 in our studies,
`lL—ll gene
`transcription (18).
`The lL—ll promoter has been cloned and the cls—elemem's
`and trans-acting fictors that regulate the level." of bacal lL—ll
`production have been ldenhfied44y our laboratories (21). De—
`sgn493the demonstrated importance of gene transcrimm.on in the
`stiw. 444la'4044 of Ell-ll prtoduomm. the (4 8elements; and trans—
`acting factors that mediate the 4,1anscriptional actwatmn of
`IL- 11 have not 7434344 investigated. To forthcr our understand-
`ing of the regulation of Ill-ll, studies were undertaken to
`
`characterize the 1:414. scrip onalclemenlsu.
`13d by'.
`19431444
`
`
`the stimulation (:1: IL-ll. These :‘tudic: identifv 4m;- actlva ling
`
`prr'
`44-1 (Al‘-
`) motifs between 3331603 and "’82 in the lL—ll
`promoter that are essential for 'l‘GF-,8-44'4d14ced lL-l] transcrip-
`
`tional activation They -also demonstrate that this stimulation
`43 assocmicd with complex alteramons in the compomtion ol'thc
`ARI subunits that bind to these sites and that DNA which
`contains these AP—l elements confers TGIF—4'31 resoonsivcness
`or. a heterologous promoter. Lastly they demonstrate that this.
`mechanism is stimulus-Specific since respiratory syncytlal Vl-
`rus (RSV) stimulates IL-ll
`transcription via a different
`mechanism.
`
`EXPEth/IEN TAL PROCEDURES
`
`Cell Culture and TGF—B, Stimulation
`
`A4549 human alveolar epitheli:
`the cells were obtained from the
`American Type Culture Collection {ATOQ Rocha/ills, MD) and grown to
`
`
`confluence in Dulbe
`’s modified Eagl
`’ medium {DMEM) supple-
`
`mented with 10% (’9.
`1 bovine 594444444 (2 ). A1. coni'lussru‘c. van/Eng con-
`
`centrations of recombinant 1444444341 TGF-fi
`(1—10 44;;4’344‘4) (R ("2 D Sy‘
`
`terns7 Minneapol;
`) or 444436144440 controls Vv
`arlded, and the :
`we
`
`
`lncuhatefi. for up to 48 h. Al: the deswed points .114 Lime, s44;
`.matan
`
`were rcmov :3 and stored at —20 ”C. and mm
`
`0 haw .ted for
`further 44noge (see below).
`
`This paper is avaxlablc on line at hiip:/wv4w ihcorg
`
`Ex. 2001 - Page1547
`Ex. 2001 - Page1547
`
`
`
`
`
`14143:41401;papmlumoq
`
` ’4.
`{4’4
`
`'3113‘St}I
`
`
`
`910:‘1[.IaqmaAoN140£010431193{OK1544112
`
`
`
`
`
`

`

`
`TGF- {.l Stimulates ILKZ Z Transcription
`’1"? ed
`The DNA trad ments with that- various 5" deletions we 'e then ..
`
`
`
`by electrophoresis. electrr :iuted, and ligated into BamHI/i hol-
`
`li earls-ed pXPZ—luc vector Clones from the suhseq uent transforms 1011
`
`were screened for insert
`an, and DNA sccucncing was used to verify
`junction sequences for all clones that w ere chosen for further
`utilization.
`
`‘, a series m" com
`Through the combined efforts at both z'pproacli
`
`---728 to ~81. ln
`structs were prepared whose 5" ends extended fro J
`
`
`
`all cases. the 3’ end was +58 rela .379 to the tra
`ription initiati .n
`site.
`
`Nye/car R11 nr-on Assay
`
`‘ative rates of gene transcription were assessed using mod
`
`
`
`
`
`.d by our laboratory (22 25..
`cations of protocols previously -:l
`A549 cells were incuhaterl For 18 h under control conditions, With
`TGF—fil (10
`ml), or after infection with respiratory syncytial virus
`
`(RSV) at a inultiplimty of infection of 3 as described previously (17—19).
`The cells (3 K 107 per condition) were then washed twice with ice-cold
`
`
`phoe
`a 3 huffere-
`.
`ine.pel .
`d, and re . spended inl
`uft'erl'm
`
`mM Tris-HCl, pll 7.4.
`:3 mM Maul? 3 mM Call”), 3 41.er dithiothreitol
`
`
`(D‘ T), 300 mM sucrose, 0.5% ‘ riton X400). The nuclei were then
`harvested by cuntrifugation and resuspended in 100 lid of storage butter
`(50 D‘lM Tris-HG}, pl-l 8.3, 3 mM MgCl% 0.1 mM Ell'l‘A, 40% glycerol) and
`stored at "-60 “C until further utilized. Nylon membranes were pre-
`
`pared carrying 20 ug a”
`h of isolated cDNA fragments encoding lI.-1‘.-
`(a gift of Dr. Paul Schendel, Genetics lnstitute, Cambridge, MA] and
`
`pUClS without- a cDNA i
`t (a con rol for nonspec ""c h‘ “urn: 'zation)
`
`
`using a slot-blotting apparatt
`{MINLFOLD ll, Schleic ier Sr Scour
`and halted in a vacuum oven \80 “C [or 2 h). VVheu rea'l
`nuclei were
`thawed on ice and pelleted in a microcentrifuge at 4 °C
`30 s. and in
`
`(zit/"o transcription and RNA labeling were carried out in transcription
`
`buffer {20 min Tris—HCL pH 8.3, 160 mM KCl, 4.5 mM MgCl, 2 mM DTT,
`and 409 MM each of ATP, GTP, and CT?) in the presence of 200 ;.:.Ci of
`ia-‘EZFIUTP {“3000 (.li/nnnol, Amersham Corp.) and 20% glycerol at
`
`‘30 °C for ‘3-3 min. Tl
`ction w followed with a cold
`.
`‘
`
`
`of lOll in}? UT? for 10 min t 30 °C. The re
`tion was then terror
`.
`
`by incubating with stop butler (50- 111M Tris—HCl, pH 83 500 mM NaCl,
`5 mM EDTA) with 200 itg’n‘il RNase-free DNase I and 750 units.i
`l
`Ranin (BL ‘hringox” ltlannheim) at 30 °C for l5 min. RNA was can
`
`
`
`tracted s i
`r phenol/chloroform, precipitated, and washed
`i alcohol.
`
`Dried RNA pellets were dissolved in equal volumes of TE huff
`(10 mM
`Tris-Hal and l mM EDTA. pH 7.x“ and i‘arlioacti'
`'
`' was determined by
`
`
`
`
`the mean of duplicate countings of l-ul aliqut
`Hybridization Vv
`.
`performed by incuhatingr each membrane with equal numbers of counts
`of radiolaheled RNA. The membranes were then washed at high strin—
`
`gency, and binding was evaluated 1. sing autoradiography.
`
`Pr
`
`
`, iter Extension Antily
`
`A549 cells were incubated for 16 h with TGF-[fi1 (10 ng/ml). T
`super atant.
`. then removed, and polyiAl’ RNA wa
`‘olated using
`
`
`
`olign(-
`) affix-:ty hased methodology as descriherl (2F 97). Primer ex"
`
`
`
`tension a" i then performed usi'l _.;‘ a radinlaheled ZO-l
`c rnplernen-
`.:
`
`tary synthetic o
`onucleo
`
`e corresponding to o
`onuclec ides --11 to
`
`
`
`+9 with respect t
`the tran
`"on start site. The 5’ end of the resulting
`using the Moloncy rnurinc leukemia virus
`TL»!
`iiiRNA was defint
`e
`primer extension syster
`(l’romega, Madison, WI) as desc ”ibed by tl~
`
`manufacturer. In this ,
`.cm the 5’ end-labeled oligonuclcot “lc hybrid--
`
`
`iaed with the ill-11 inh‘NA and was uti
`ed a 2. primer by the Molouey
`niurine leukemia Virus reverse transcriptase which, in the presence of
`deoxynucleotides, synthesized cDNA until the 5 end of the mRNA was
`reached. The extended product was then resolved on an 8% urea/
`
`
`polyacwlanide sequci
`ing gel along with a known DNA sequence
`ladder.
`
`U0
`1
`8a.rna.
`
`EE
`
`3:5
`5‘:
`
`
`
`ifiio‘J.
`
`910:‘1[requiemNno£01013nagIOK15H]12
`
`Site-directed .Mutuge‘nesis
`Mutation of the Al’ul sites in the parent lL-ll promoter was per-
`
`
`
`l’ormed usii g the Mute-G en M13 In Vino Mutage
`Kit (Bio-Rad,
`
`catalog numuer 170—3580} l3
`‘ed on Kunkel’s method (29, 30‘), The
`382-bp Bomlll/thl fragment 0-” Ill-11 promoter was excised from
`
`
`le’Z-lli—l 1—324 and su'bclon d into M13 phage. The recombinant plu
`
`DNA was then transformed into bacterial
`
`train Eschc 'c.’ in cali CJ236
`(dut—, ung—,
`thi—, and relA—l to generate uracil-containing single—
`stranded DNA. Such singlenstranded DNA was allowed to anneal to
`mutagcnic primer, and second strand DNA was synthesized with T7
`
`
`
`DNA polyn
`and T4 D .'A ligas . When transihr \ed into hart
`.1
`strain M‘Jllgfltdt
`, ung+), omen-containing sin_
`stranded DIVA
`
`
`template was degraded, and only newly synthesized mutation-hearing
`second strand DNA. would propagate. The wild type and mutated ARI
`
`
`sequences are as follows: wild type 5’ (dist ll AP-
`. 5’-TGAGTC;
`;
`
`
`
`in ut
`ted 5" (dis
`l Al’ul, 5"-'llGAcgaA—3’; wi
`. tvpe 3" (proziniall All-l,
`
`5"n'l‘
`ETTA—3’; mutated 3’ (proximal) AP-l, 5’—TG'l‘c raA—fl’. All nt'the
`AP-l mutation cons tructs underwent DNA sequencing to verify the site
`and extent of the induced alterations.
`
`
`Preparation of [Ir 7 i / He / .m‘ Constructs
`
`A 156-bp BomHL’XhoI f agmcnt ”rem thc herp
`mplcx Virus thy-
`midine liinase ltk) minimal pron’ioter/chloramphenicol acetyltrans—
`ferase reporter gene construct ptli—CAT (313 was obtained from Dr
`
`and sulicloned into the.
`Annradha Ray (V ' U. '
`tensity, New Haw
`
`
`BamHI and X01
`
`
`of the pXFZ‘; uc re orter gene construct
`to
`
`
`generate ptk-XPZ.
`cleotides (5’-GA_ COG AGG GTG AGT
`GAG GAT GTG ’T‘CA (”Kiri") CG AGC TT-B" and 5—6231“ CAA GCT TCG
`
`GCC TGA CAC CTG ACT CAD CCT CG-B’l Vere then ‘vnthesized and
`
`
`annealed to form a 538-bp DNA duplex with sticky ends compatible witl
`the ,i’iomlll site (5" of herpes simplex Virus tk promoter! in ptk V332.
`This insert conta s a 27—hp DNA seq uence ofthe IL~11 promoter
`03
`
`
`to — 7'? relative to transcription start site) t lat contains hoth the 5’ and
`3"
`. l‘his double . tranded DNA sequence was then cloned into
`
`
`
`p
`P2 in the correct (sense, (plLll-(+ )tk—XPZ) and reverse (ant
`2)
`
`(plLlll—ltk—XPZ) directions. DNA .
`uencing was performed to verify
`the sequence and orientation of DlKA insertion.
`
`Coll ' 'mizsfcctinn and Reporter Gene Assay
`
`A549 cells were at éded at 40—50% confluence and i
`'uhated over-
`
`
`night in DMij w
`higl glucose and 10% fetal bovine s rum. Trans—
`
`
`
`
`fecti
`s were performed using the DEAE-r, xtran method a describe-“l
`
`
`
`prcvxoos ‘ bv our lahorator r
`. The cells were then incubated for 2- n
`
`
`in
`urn—tree DMEM alone or in DMEM supplemented with TGFfil {10
`
`rig/ml). in experiments where RSV was utilized the A549 ce ‘5 were
`
`
`incuhaterl for 9-3 min with RSV (inultiplir v m” infect-.011. ; 3) or appro—
`priate medium control. washed and then A icuhated for 24 h in serumx-
`ire DMEM. At the end of these incubations, cell lysates were prepared7
`and luciferase activity was assessed on a Lumat luminometer using the
`
`
`
`Lucite-ruse Assay S
`cm from Promcga (Madison, V ll). In all trans :30-
`
`
`
`tions the construct pGl‘i/l'l-O-gal (CliiONTEC-H, Palo Alto, CA) was a,,,.so
`included to control for transfection efficiency. The B—galactosidase ac—
`
`
`ti v ity in unstimulal ed and sti ulaied cell lysates was character
`d
`
`
`u ' .g the CPR 3 method as descrihed previously h.
`' iis lahora tory ( “,_
` ya.
`
`
`ihe B-galactosidase levels were then i. ' ed to standardize the ins
`merits of lucii’erase activity.
`
`EZezfif/‘ophureiic M’nhiliiy Shift A my (Ed/IS; )
`
`
`Preparation of Nuclear Er’racts --Nuclear extracts were prepared
`
`
`
`
`. .g morli . .
`ions of the
`i niques of S
`reiber et al. (32). Unstimu-
`
`lated7 'l‘l'lll'fifs inulated, and RSVlini‘ected . 549 cells were prepared
`as noted above. At the desired points in time, the cells {107 per condi-
`tion) were mechanically detached. suspended in Tris-buffered saline
`
`freshly supplemented with protease ii:
`ihitors (l pig/ml leupeptin, 5
`lag/ml aprot-inin, and 1 mM phcnylmcthylsultbnyl fluoride), pelleted at
`4- "C, and resuspended, and swollen in solution A (10 mM HEPES, pH
`
`Ex. 2001 - Page1548
`Ex. 2001 - Page1548
`
`P1asm Ed Construction
`
`A 786-bp Pvull fragment of the human lL—ll promoter was previ-
`ously isolate.“ and cloned in our lahnra .nries (21:). This promoter frag—
`ment contain.
`uences hctween —728 and +5.8 relative to the
`
`transcri
`tion start site defined above. it was cloned into the Smal site
`
`of the i ciferase reporter gene vector pXPZ—luc (A- CC) to generate the
`construct le’Z—llrl 1-‘7‘ 8.
`
`Preparation uf5’ Deletion Constructs
`
`
`
`Two techniques were used to gel
`e a series of 5" dele‘ one of the
`plill2-llii—11-7238 parent construct. When appropriate restriction sites
`
`were present, they were util.,. d to generate dele
`n mutants. This
`
`
`approach was u
`zed with theA ..
`the Hinfl site at
`
`--96. In both -':ases7 the »--728 to +58 iragment
`the IL~11 promoter
`
`
`
`
`
`was suhjected to cnzyr
`di
`'on. an
`the desired fragment '
`; re--
`cloned into the vector pLX'PZ-luc using standard approaches. ‘thn on
`
`propriate restr'ction sites were not available Bal -‘ i exonuclease diges-
`
`tion was employed to introduce
`eti as. This technique takes
`advantage oi'tlie Fact that Hal-Ell de‘ rides hath the 5’ and 3’ enrls ol’
`
`double-stranded DNA without inserting internal cleav
`‘8). Briefly,
`BamllI-linearized parent construct pXPQ-ll.-l1-324 was incubated
`with Bail-31 one-nuclease for varying periods. Hamill linkers (New
`England Biolahs, catalogue number 1071. Beverly. MA) were then
`added, and the DNA was subjected to BumHl/thl double digestion
`
`

`

`5508
`
`incubation Conditions
`
`]
`
`TGF—[E Stimulates IL-Il Transcription
` 1 mm DTT with l} eslily
`7.9, 10 mM KCl7 0.1 niM EDTA, 0.1 mm EGT
`added nro
`inhibitors as abov
`br 15 min on i Membrane lysis
`
`
`
`
`
`‘ complished by ad’ ing 25 ,ul of Nonidet P-I‘Q fol-g veal by vigorous
`
`
`
`
`
`agitation. The nuclei w . o coll..ctc(l by ccntnfugntion, rcsuspcndcd in
`5-5) ,u.l ofsolution B (20 mM HEPES, pH 7.9, 460 mM NaCl, 1 mM EDTA.
`1 mM EGTA, 1 mM‘ DTT and freshly added protease inhibitors as above).
`and agitated vigorously at 4 ”C lbr 15 min. The membrane. debris was
`discarded, and the nuclear extracts were snap~fiozen in small aliquots
`and stored at —80 “C.
`r(, ein concentrations of the nuclear extrac s
`
`were determined using t e DC Protein Assay System (Bic—Rail).
`Oligcnuclcotide Prob
`.
`probes
`
`were used in these experiments. For the Make of simplicity, only the top
`
`strand DNA sequences are illustrated l'
`e. Four oligonucleotide probes
`
`were syiitli
`'(l Using the (:iligonucleutiile synt
`lity at Yale.
`
`
`
`
`University. T M ii ch. lo the lbllmving ti) wilol type 5’ AF-l sequence in
`the IL—ll promoter (5' AP-l) (5’~GGGAGGGTGAGTCAGGATGmG-B’D;
`
`(ii) mutated 5’ AP-l (EH-{XX}: GGGTGA-ega/XGGATGT“3'); (iii) wild
`type 3’ AP-l sequel: .3 in the ill—ll, promoter (3 AP-l) (LR—AGTCAGG—
`ATGTG’l‘CAGGCCGGCCl‘ 3' J; and (iv) mutated 3" AP-l (5’~AGTCAG—
`
`GATGTcgaAGGCCGGC-CC ’),
`Four other oligonucleotides were obtained from commercial sources
`(Stratagene, La Jolla, CA). Th
`included the following: (i) a Classic
`
`
`AP-l nligonucleotiile (5"~CTAGTGATGAGTCAGCCGGAT‘CJ {3; (ii) an
`APE oligonuclcotidc (5’—GATCGAACTGACCGCCCGC ‘GCCCGT—3’);
`(iii) an ASP—3 oligonucleotiile (-5‘-CTAGTGGGACTTTCCACAGATC-S’l;
`and (it/‘1 an 89-1 oligonncleotide (5'-GAT(JGATCGGGGCGGCrGCGA’ll
`(13’).
`
`
`E743
`'trophorc" EMSAS were performed using the techniques of
`r at a].
`(3'2). Eadiolabeleil donhie-stranded
`,
`,‘onucleotio‘e
`Sr,
`
`
`probes were prepared by annealing complementary oligonucleotides
`
`and curl—labeling using [y—MP‘ATP and T4 polynuclcotidc kinasc (New
`England Biolabs‘;. The labeled probes were purified by push—column
`chromatography. diluted with TE bufi'er (10 mM Tris-HUI. pill 80 1 mM
`ED‘T‘A) to the desired concentration, and incubated with equal aliquots
`oi'nuclear extract (2--5 egg) and 2 a}; ofpolyldI-dCl~polyldl-dCl in a total
`volume of 20 Ml at room temperature for 1 11. Resolution was accom-
`
`plisheu by electro plioresing‘ 10 ,u.l of the reaction sol ution on vertical 6%
`
`native polyacrylamide gels containing 2% glycerol using
`'70 TBE
`X)
`
`buffer '
`3 niM Tris-Hm, 22.3 mm boric acid, {1.25 mil EDTA, pH 8.0).
`Binding was assessed via ziiitnrarliograpliy.
`Supershi/Z EflfSAm-SLiperésliil’t assays were used to determine w }lCli
`members of the AP-l family were involved in TGF/sttimulaLion or"
`
`lL—ll gene transcription in t
`‘ studies EMSA were performed as
`
`
`descrihci above except tl
`sntypo matched rabbit pol
`onal antibod—
`
`ies against AP—l proteins or control preimmuue ant erum were in-
`
`
`cluded (in: 'ng the Li) rad'
`labeled probe extract incubation period. All
`of the antibodies. that were used were purchased from Santa Cruz
`Biotechnology (Santa Cruz, CA). They included antibodies that react
`with all Jun family members (Pan-Jun) (catalogue number SC-44X),
`
`JunB (catalogue number 46X), JunD (ca 'l one number SCI-74X). c—Jiin
`
` or SCSZAZX): all Fos fa
`(catalogue nu
`‘
`y members (pan—Foe) (cata—
`
`logue number tail-253$, c-Fr {catalogue number SC-oZX), FosB (cat-
`
`alogue number Bil-48X). Fra-
`:a Lalogiie number S l—EO‘SX). and Fro-2‘:
`((Iltalogue iiuuilier ECG-34X}.
`
`
`RSV (13142 strain) was obtained from the ATCC. Stock virus was
`
`prepar; I
`in permissive cell lines and titered, and A549 cells were
`infected with the virus as described previously by this laboratory
`(17, 19).
`
`RESl Il IFS
`
`TGF—BI and RSV Stirrzulatc i’L-Z 1 Gene Trans '«
`
`vious studies from our laboratory demonq rahxl ,
`a potent stimulator of lL—ll gene transcription in lung fibro—
`blasts (18‘) and that TGEi’il and RSV stimulate A549 alveolar
`epithelial cell ILll protein production and mRNA accumula—
`
`tion (1?, 19). To determine ii" hoth slti
`iuli augment 111"].1 gene.
`transcription in A549 cells. nuclear :un—on assays were per-
`formed, and the levels of lL—ll gene t anscription were evalu—
`ated at base line, after TGF—[31 stimulati‘n and after RSV
`infection. At base line, the levels of IL—11 gene. transcription in
`A549 cells were near the limits of detection Vi. ith our assay (Fig.
`1). In contrast. both TGF—Bl and RSV caused significant. in-
`creases in IL-ll gene transcription (Fig. l).
`
`
`
`
`
`.1111;11101;popmlumoq
`
` r:
`
`'0rd.in
`
`
`
`
`
`910:‘1[ioqmvoNnoEmma1193{OK1qu12
`
`9136
`
`15:11
`
`l
`
`
`
`FIG. 1'. Demonstration of the effects of TGF-[fil and RSV on
`
`IL] I gene transcription. A54?) c9
`, incubate“ in medium alone
`
`(Control), stimula toil with TGF:
`r5113) (l0 ng/nill, or infected with
`
`
`RSV. Twenty four hours later their nuclei wer
`:aryested, and gene
`transcriotion was assessed as described undcr “ltlxpcrimontal Proce—
`dures
`ie lcvo s of Ill-ll, gcuo transcription arc coinparcd with the.
`
`liybridim...ion noted with QUCIS (DUO) without a CDNA insert which
`served as a negative control.
`
`3haram‘erization of t

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket